In IBS patients, the NF-κB/IκB-α pathway activation in mucosal macrophages fostered the expression of inflammatory factors like NLRP3, leading to increased secretion of IL-1β and TNF-α (65). Here, NFKB1 is linked to irritable bowel syndrome.